Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...

Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids can deposit in any tissue or organ, including the heart, kidneys, liver and ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways The diagnosis of cardiac ATTR amyloidosis is frequently missed or ...

Please provide your email address to receive an email when new articles are posted on . Many patients with amyloidosis take years to be diagnosed. New ASH guidelines make 12 recommendations to improve ...

Uncover the latest and most impactful research in Amyloidosis Diagnosis and Treatment Strategies. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field ...

The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...

A case report describes an exceptionally rare instance of wild-type transthyretin amyloidosis confined to the ...

A new review paper was published in Oncotarget, titled "Systemic AL amyloidosis: current approach and future direction." In this review, researchers from SUNY Upstate Medical University, University of ...

Transthyretin-mediated (ATTR) amyloidosis is a multisystem disease caused by the abnormal deposition of misfolded transthyretin protein as amyloid fibrils in various tissues. ATTR amyloidosis presents ...

Amyloidosis denotes a heterogeneous group of protein misfolding disorders characterised by the extracellular deposition of insoluble amyloid fibrils in multiple organs and tissues, resulting in ...

This weekend is the Richard S. Caliguiri Great Race, named for the late former Pittsburgh mayor.